leisure time -WSS

leisure time

author：Wikipedia 2025-10-04 04:01:27 - browse：7618

Powdered ibogaine against a white background. — Tabernanthe iboga, the shrub that contains the psychedelic substance ibogaine. Wikimedia Commons

The psychedelic ibogaine is unlikely to ever receive approval as a treatment for opioid addiction, the federal government’s top addiction researcher said Thursday.

The remarks from Nora Volkow, the longtime director of the National Institute on Drug Abuse, serve as a cautionary note amid widespread enthusiasm about ibogaine, a naturally occurring substance that drug companies and researchers have increasingly cast as a potential paradigm-shifting addiction treatment.

But its potential cardiac side effects could stand in the way of receiving approval from the Food and Drug Administration, Volkow said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Why sickle cell disease is getting the first CRISPR treatment

WSS

STAT Health News: mRNA flu shots, Purdue SCOTUS case, etc

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Nurses recount patients attacks

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Physicians and social media: If you see something, say something?

knowledge

leisure time

entertainment

The cancer drug shortage isn’t new — and neither are the solutions

App could help diagnose ear infections more accurately — and at home

After affirmative action ruling, medical educators look to 'holistic review'

Congenital heart disease patients face new threat of heart failure

As demand for Covid shots wanes, Moderna seeks its next success

Spinal cord stimulation reduces pain in amputees, study finds

Peter Hotez and the public health issue of online harassment

AstraZeneca to buy developer of next

Hepatitis C has a cure — but many Americans still lack access to it

U.K. researchers warn about biases in medical devices, algorithms

entertainment

What PEPFAR has meant on the ground in Ukraine

Colonoscopy prep: Liquid

Plastic surgeons increase patient psychiatric screenings

STAT letters to the editor on burnt

STAT letters to the editor on burnt

Argenx readies a blockbuster opportunity with drug for autoimmune disease

focus

focus

knowledge

leisure time